Abstract:Bacterial infections have become a global public health problem in recent decades, mainly due to infections caused by Gram-negative bacteria with antibiotic resistance profiles, which were responsible for over 3 million deaths in 2019. Polymyxin B (PMB) and polymyxin E (PME or colistin) are cyclic cationic polypeptide antimicrobials that have re-emerged in clinical practice due to the high rates of morbidity and mortality in infections caused by Gram-negative multidrug-resistant or extensively drug-resistant. Although polymyxins have antibacterial potential, they still have low stability and adverse effects, thus limiting their administration. To overcome these limitations, the use of controlled release systems such as liposomes, nanoparticles, and nanotubes is a viable strategy. Therefore, the objective of this review article is to present recent studies that address the antibacterial activity of PMB and PME encapsulated in nanocarriers against Gram-negative bacteria and to highlight the advantages of these nanocarriers and how they can overcome polymyxin limitations and bacterial resistance to polymyxin, as well as increasing drugs efficacy and safety. The preparation of this narrative review was based on the following steps: identification of the theme, establishment of inclusion and exclusion criteria, analysis and selection of articles, interpretation of data and results, and the writing of this article. Nanoparticles, electrostatic nanocomplexes, nanostructured lipid carriers, liposomes, and halloysite nanotubes can enhance bacterial activity from both PMB and PME, reducing minimum inhibitory concentration, inhibiting and eradicating biofilm, as well as prolonging polymyxins activity, reducing toxicity, and improving bioavailability. The strategy of encapsulation of polymyxin in nanocarriers has demonstrated a significant enhancement in polymyxin activity and pharmacokinetics, resulting in elevated therapeutic efficacy. Therefore, nanocarriers containing polymyxin emerge as a promising and innovative strategy to address this global challenge in public health.

Synthesis of polymeric nanoparticles by double emulsion and pH-driven: encapsulation of antibiotics and natural products for combating Escherichia coli infections

Polymeric Nanoplatforms for the Delivery of Antibacterial Agents

Nanoparticle-based Local Antimicrobial Drug Delivery

Unleashing the power of polymeric nanoparticles - Creative triumph against antibiotic resistance: A review

Soft nanoparticles as antimicrobial agents and carriers of microbiocides for enhanced inhibition activity

Antibacterial Activity of Polymyxins Encapsulated in Nanocarriers Against Gram-Negative Bacteria

Naturally-Sourced Antibacterial Polymeric Nanomaterials with Special Reference to Modified Polymer Variants

Review on PLGA Polymer Based Nanoparticles with Antimicrobial Properties and Their Application in Various Medical Conditions or Infections

Silver-Sulfamethazine-Conjugated β-Cyclodextrin/Dextran-Coated Magnetic Nanoparticles for Pathogen Inhibition

Nanocomposites: silver nanoparticles and bacteriocins obtained from lactic acid bacteria against multidrug-resistant Escherichia coli and Staphylococcus aureus

Arachidonic acid induces augmented vasoconstriction via cyclooxygenase 1 in the aorta from rats fed a high-fat diet.

Silver and Antimicrobial Polymer Nanocomplexes to Enhance Biocidal Effects

Neuropeptide galanin inhibits omega-conotoxin GVIA-sensitive calcium channels in parasympathetic neurons.

Polydopamine Nanocarriers with Cascade-Activated Nitric Oxide Release Combined Photothermal Activity for the Therapy of Drug-Resistant Bacterial Infections

Antibiotic-conjugated polyacrylate nanoparticles: new opportunities for development of anti-MRSA agents.

Regarding: Impact of portal vein resection on oncologic long-term outcome in patients with hilar cholangiocarcinoma.

Polymeric nanoantibiotics based on two orthogonal binding motifs coalesce with bacterial matter

Prevalence of Non-thrombotic Iliac Vein Lesions in Patients with Unilateral Primary Varicose Veins.

Synthesis, Characterization, and Biological Evaluation of Chitosan Nanoparticles Cross-Linked with Phytic Acid and Loaded with Colistin against Extensively Drug-Resistant Bacteria

Mesoporous Silica Nanoparticles Decorated with Polycationic Dendrimers for Infection Treatment